The D/I polymorphism in the angiotensin-converting enzyme gene and chronic obstructive pulmonary disease risk: A meta-analysis

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 9, Issue 5, 2012, Pages 485-491

  Li, Xiaobo ^a   Wei, Na ^b   Wu, Zhangjun ^c   Qi, Zhanzhong ^a   Zhang, Xin ^a   Chen, Qiuling ^a   Xia, Zhiqiang ^a   Li, Shuo ^a  

^a 452 Military Hospital of China   (China)

^b Second Department of Internal Medicine   (China)

^c Department of Laboratory Medicine   (China)

Author keywords

ACE; COPD; Meta analysis; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; ASIAN; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; DATA BASE; DNA POLYMORPHISM; EMBASE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INDEL MUTATION; MEDLINE; META ANALYSIS; POPULATION; PRIORITY JOURNAL; RACE; SEX DIFFERENCE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INDEL MUTATION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84867060015     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2012.694921     Document Type: Article

References (24)

1. Soriano JB, Rodriguez-Roisin R. Chronic Obstructive Pulmonary Disease Overview: Epidemiology, Risk Factors, and Clinical Presentation. In: Am Th oracic Soc; 2011:363.
2. Halpin D. Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena. COPD 2008;5:187-200.
3. Bracke KR, Dentener MA, Papakonstantinou E, et al. Enhanced deposition of low-molecular-weight hyaluronan in lungs of cigarette smoke-exposed mice. Am J Resp Cell Mol 2010;42:753.
4. Hallberg J, Dominicus A, Eriksson UK, et al. Interaction between smoking and genetic factors in the development of chronic bronchitis. Am J Resp Crit Care 2008;177:486.
5. Smolonska J, Wijmenga C, Postma DS, Boezen HM. Metaanalyses on suspected COPD genes-a summary of 20 years' research. Am J Resp Crit Care 2009:200722-200905.
6. Sorheim IC, DeMeo DL, Washko G, et al. Polymorphisms in the Superoxide Dismutase-3 Gene Are Associated with Emphysema in COPD. COPD 2010;7:262-268.
7. Lee J, Nordestgaard BG, Dahl M. EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis. Eur Respir J 2011;37:18.
8. Zhong L, Zhang YP, Fu WP, et al. The Relationship between GSTP1 I105V Polymorphism and COPD: A Reappraisal. Am J Resp Crit Care 2010;181:763.
9. Shukla RK, Kant S, Bhattacharya S, Mittal B. Association of Genetic Polymorphism of GSTT1, GSTM1 and GSTM3 in COPD Patients in a North Indian Population. COPD 2011;8:167-172.
10. Zhan P, Wang J, Wei SZ, et al. TNF-308 gene polymorphism is associated with COPD risk among Asians: meta-analysis of data for 6,118 subjects. Mol Biol Rep 2011;38:219-227.
11. Zhang X, Wang C, Dai H, Lin Y, Zhang J. Association between angiotensin-converting enzyme gene polymorphisms and exercise performance in patients with COPD. Respirology 2008;13:683-688.
12. van Suylen RJ, Wouters EF, Pennings HJ, et al. The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease. Am J Resp Crit Care 1999;159:1791.
13. Kanazawa H, Okamoto T, Hirata K, Yoshikawa J. Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. Am J Resp Crit Care 2000;162:1235.
14. Ahsan A, Ram R, Baig MA, Pasha MA. ACE I allele and eNOS G allele crosstalk may have a role in chronic obstructive pulmonary disease. Clin Biochem 2004;37:1037-1040.
15. Gu HT, Zhang HS, Yang L. Relationship between polymorphism in the angiotensin converting enzyme gene and susceptibility to COPD(Chinese). Ji Chu Yi Xue Yu Lin Chuang 2003;23:174-177.
16. Hopkinson NS, Nickol AH, Payne J, et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Resp Crit Care 2004;170:395.
17. Jiang CC, Zhang LH. The correlation between the polymorphism of angiotensin-converting enzyme gene and the risk of COPD(Chinese). Guo Wai Yi Xue Lin Chuang Sheng Wu Hua Xue Yu Jian Yan Xue Fen Ce 2002;23:248-249.
18. Pabst S, Th eis B, Gillissen A, et al. Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease. Eur J Med Res 2009;14:177.
19. Tka?ova R, Joppa P, Stan?ak B, et al. The link between angiotensin-converting enzyme genotype and pulmonary artery pressure in patients with COPD. Wien Klin Wochenschr 2005;117:210-214.
20. Wang HW, Nie ZS, Duan YZ, et al. The correlation between the polymorphism of angiotensin-converting enzyme gene and the risk of lung cancer and COPD(Chinese). Hai Jun Zong Yi Yuan Xue Bao 2000;13:203-206.
21. Yildiz P, Ofl az H, Cine N, et al. Gene polymorphisms of endothelial nitric oxide synthase enzyme associated with pulmonary hypertension in patients with COPD. Resp Med 2003;97:1282-1288.
22. Zhang X, Wang C, Dai H, Lin Y, Zhang J. Association between angiotensin-converting enzyme gene polymorphisms and exercise performance in patients with COPD. Respirology 2008;13:683-688.
23. Chapman KR, Stockley RA, Dawkins C, Wilkes MM, Navickis RJ. Augmentation therapy for ?1 antitrypsin defi ciency: a meta-analysis. COPD 2009;6:177-184.
24. Zhang YG, Li XB, Zhang J, et al. The I/D polymorphism of angiotensin-converting enzyme gene and asthma risk: a metaanalysis. Allergy 2011;66:197-205.